Clinical Trials Insight: 700015338
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2009
At a glance
- Drugs ADX-10059 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- Sponsors Addex Therapeutics
- 08 Aug 2009 Results reported in Gut.
- 08 Aug 2009 Primary endpoint 'Time with oesophageal pH less than 4' has been met.
- 19 Apr 2007 Status change